NCT03360071View on ClinicalTrials.gov

A Novel Biologic Therapy for Perennial Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

November 1, 2018

Conditions
Allergic Rhinitis
Interventions
DRUG

Allergen Immunotherapy Extract

Allergen Immunotherapy treatment mixture to be delivered subcutaneously

DRUG

Allergen Immunotherapy Control

Allergen Immunotherapy Control Solution to be delivered subcutaneously

Trial Locations (1)

21224

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03360071 - A Novel Biologic Therapy for Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter